📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

825 Symptomatic glucocorticoid -induced adrenal suppression (AS) in the UK and Ireland- results of a BPSU study (2023)

First Author: Barlow H

Attributed to: Molecular determinants of immune tolerance in Graves' disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/archdischild-2023-rcpch.417

Publication URI: http://dx.doi.org/10.1136/archdischild-2023-rcpch.417

Type: Conference/Paper/Proceeding/Abstract